Y452 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÇÁ·ÎÇǿ»êÀ¯µµÃ¼ | Propionic acid derivatives causing adverse effects in therapeutic use |
|
Y452 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÇÁ·ÎÆijë»êÀ¯µµÃ¼ | Propanoic acid derivatives causing adverse effects in therapeutic use |
|
Y453 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ºñ½ºÅ×·ÎÀ̵åÇ׿°ÁõÁ¦ | Other nonsteroidal anti-inflammatory drugs [NSAID] causing adverse effects in therapeutic use |
|
Y454 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ç×·ù¸¶Æ¼½ºÁ¦ | Antirheumatics causing adverse effects in therapeutic use |
|
Y455 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â 4-¾Æ¹Ì³ëÆä³îÀ¯µµÃ¼ | 4-Aminophenol derivatives causing adverse effects in therapeutic use |
|
Y458 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ÁøÅëÁ¦ ¹× ÇØ¿Á¦ | Other analgesics and antipyretics causing adverse effects in therapeutic use |
|
Y459 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â »ó¼¼ºÒ¸íÀÇ ÁøÅëÁ¦, ÇØ¿Á¦ ¹× Ç׿°ÁõÁ¦ | Analgesics, antipyretics and anti-inflammatory drug, unspecified causing adverse effects in therapeutic use |
|
Y46 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ç×°£ÁúÁ¦ ¹× Ç×ÆÄŲ½¼Á¦ | Antiepileptics and antiparkinsonism drugs causing adverse effects in therapeutic use |
|
Y460 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¼®½Ã´Ï¸¶À̵å | Succinimides causing adverse effects in therapeutic use |
|
Y461 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¿Á»çÁ¹¸®µð³×µð¿Â | Oxazolidinediones causing adverse effects in therapeutic use |
|
Y462 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â È÷´ÜÅäÀÎÀ¯µµÃ¼ | Hydantoin derivative causing adverse effects in therapeutic use |
|
Y463 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â µ¥¿Á½Ã¹ÙºñÃò·¹ÀÌÆ® | Deoxybarbiturate causing adverse effects in therapeutic use |
|
Y464 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â À̹̳뽺ƿº¥ | Iminostilbenes causing adverse effects in therapeutic use |
|
Y464 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ä«¹Ù¸¶Á¦ÇÉ | Carbamazepine causing adverse effects in therapeutic use |
|
Y465 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¹ßǪ·ÎÀÍ »ê | Valproic acid causing adverse effects in therapeutic use |
|
Y466 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ Ç×°£ÁúÁ¦ | Other and unspecified antiepileptics causing adverse effects in therapeutic use |
|
Y467 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ç×ÆÄŲ½¼Á¦ | Antiparkinsonism drugs causing adverse effects in therapeutic use |
|
Y467 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¾Æ¸¸Å¸µò | Amantadin causing adverse effects in therapeutic use |
|
Y468 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ç×°Á÷Á¦ | Antispasticity causing adverse effects in therapeutic use |
|
Y47 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÁøÁ¤Á¦, ¼ö¸éÁ¦ ¹× Ç׺ҾÈÁ¦ | Sedatives, hypnotics and antianxiety drugs causing adverse effects in therapeutic use |
|